Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02443415 · ClinicalTrials.gov registry record
Diabetic Ketoacidosis: Brain Morphology and Cognition
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 45
- Enrollment target
NCT02443415: Completed study, sponsored by Emory University.
NCT02443415 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02443415 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to assess brain and memory changes in patients with uncontrolled diabetes (a condition called diabetic ketoacidosis (DKA))
Primary Outcome
Changes in brain morphology will include quantitative measurements of regional cortical volume as well as of hippocampal and thalamic volumes. Change is the difference from baseline MRI and 1 month MRI.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2015-02 |
| Est. Completion | 2017-10-01 |
What the finished NCT02443415 record still lists
NCT02443415 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02443415 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02443415 about?
NCT02443415 is a clinical study titled "Diabetic Ketoacidosis: Brain Morphology and Cognition". The purpose of this study is to assess brain and memory changes in patients with uncontrolled diabetes (a condition called diabetic ketoacidosis (DKA))
What is the current status of trial NCT02443415?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2015-02. Estimated completion is 2017-10-01.
Who is sponsoring clinical trial NCT02443415?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia